Characterization of CYP26B1-selective inhibitor, DX314, as a potential therapeutic for keratinization disorders

Joachim Veit, VALERIE DE GLAS, Benoit Balau, Haoming Liu, Florence Bourlond, Amy Paller, Yves POUMAY, Philippe Diaz

Research output: Contribution to journalArticlepeer-review

20 Downloads (Pure)

Fingerprint Dive into the research topics of 'Characterization of CYP26B1-selective inhibitor, DX314, as a potential therapeutic for keratinization disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds